Reaction
Hand Dermatitis reporting signals
As of the last recalculation, Hand Dermatitis appears in 651 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is ADO-TRASTUZUMAB EMTANSINE (PRR 94.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ado-Trastuzumab Emtansine | 24 | 94.5 | 94.7 |
| Human Immunoglobulin G | 22 | 35.2 | 35.3 |
| Heparin Sodium | 13 | 30.8 | 30.8 |
| Pertuzumab | 24 | 29.3 | 29.3 |
| Crisaborole | 8 | 27.0 | 27.0 |
| Dupilumab | 251 | 26.5 | 26.5 |
| Tramadol Hydrochloride | 22 | 19.3 | 19.3 |
| Paclitaxel (Aibumin-Bound) | 32 | 13.0 | 13.0 |
| Cannabidiol | 9 | 12.5 | 12.5 |
| Nemolizumab-Ilto | 4 | 10.1 | 10.1 |
| Atezolizumab | 11 | 9.2 | 9.2 |